Certainly not ideal.... all that said, I can't help but think if there is such a good relationship with APN, and they see value.... we are a cheap TO for the capital invested to date.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025